UL Prospector

Antiacne Clinical Trials

文檔

International Research Services, Inc. (IRSI)目前只在以下作出標識的區域展示其產品資料:

OTC drugs products should undergo clinical trials of acnegenicity to evaluate the efficacy of products in the treatment of acne lesions or evaluate the acnegenic potential of the products.

The expert's assessment and/or instrumental analysis reveals important statements of support: dermatologically tested, clinically proved, antiacne, minimize the appearance of pores, oil control/reduce skin greasiness/sebum control/for acne-prone skin, helps remove dirt and dead skin cells, pH balancing, hydration, sustainably strengthens skin barrier function/helps to increase skin self-defense, and reduce inflammation.

Our team of experts statistically evaluates all the measures listed above to support OTC drug product manufacturers in claims evidence and to market potentially safe and effective skincare products.

公司

International Research Services, Inc. (IRSI) is a privately held clinical research company founded in 1977 that serves the cosmetic and pharmaceutical industries.

Specializing in dermatological safety and efficacy testing, IRSI is a leader in biophysical instrumental analysis of the effects of test products on human skin conditions. For over 40 years of history, IRSI has become a reference in the development and conduct of clinical tests for products from different markets, such as pharmaceutical, cosmetic, hygiene, food and nutrition. In partnership with Allergisa, a Brazilian company with over 25 years of experience in these segments, the tests are carried out within the strictest standards of safety, which guarantees the credibility of the products that will reach people's homes.

公司文檔

本頁顯示的信息由UL從產品廠商處直接獲得。UL始終在盡最大努力確保此數據的準確性,但是UL對於這些信息中涉及的數值或產品宣稱不承擔任何責任,強烈建議您在最終選擇產品時,就所有信息與廠商進行驗證。

類別

設備/服務 Categories